Career Background

• Over 25 years of experience in healthcare as a surgeon, executive and investor
• Managing Director, CBC Group(2021-present)
• CEO Greater China Parkway Pantai Limited (2018-2020)
• Managing Director, Vertex Venture Management, a venture subsidiary fund of Temasek Holdings (2013-2017)
• Technical advisor, National Research Foundation (NRF) Central Gap Fund (2017-2018)
• Operating Partner (2013-2014), Industry Advisor (2015-Present), Advent International, a global private equity firm with more than US$ 40B AUM
• CEO and Board Member, Quality Healthcare, Hong Kong’s first publicly listed healthcare company (2003- 2012)
• Notable past investments include Visterra (acquired by Otsuka Pharmaceutical in 2017), Jinxin Fertility (listed on the Hong Kong Stock Exchange), Twelve (acquired by Medtronic), Arana Therapeutics (acquired by Cephalon), Biosensors International (IPO) and Phoenix Hospital Group (IPO), Quality Healthcare (acquired by BUPA International).

Board Experience

• Non-Executive Board Member, Earlens Corporation (2016-2017)
• Non-Executive Board Member, Holaira (2014-2017)
• Non-Executive Board Member, Sensimed AG (2014-2017)
• Non-Executive Board Member, Visterra, Inc (2014-2017)
• Independent Non-Executive Director, Biosensors International (2009-2010)
• Non-Executive Director, Arana Therapeutics (2006-2008)

Education/ Awards

• MBBS, National University of Singapore
• Fellow of the Royal College of Surgeons Edinburgh and a Fellow Academy of Medicine Singapore in Otorhinolaryngology Head & Neck Surgery
• Executive Education, Business and Finance, Harvard Business School and Michigan Ross School of Business
• Outstanding Entrepreneur of Hong Kong, Asia Pacific Entrepreneurship Awards